HEROSTEM BIOTECHNOLOGY
Changchun
About HEROSTEM BIOTECHNOLOGY
HEROSTEM BIOTECHNOLOGY focus on stem cell research and clinical applications and have completely independent intellectual property rights in stem cell technology. The stem cells are derived from early adult tissues and are the earliest stage stem cells that can be extracted. Their business scope includes umbilical cord, placenta, umbilical cord blood stem cell preparation and storage services, and more.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Total funding: $2.3M
- Funding stage: Early Stage Venture
- Last round: Series A (Nov 2015)
- Website: jlhuirong.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Medical
Canonical: https://fsome.com/organization/herostem-biotechnology-2648748 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.